Literature DB >> 33115878

Control of Archetype BK Polyomavirus MicroRNA Expression.

Wei Zou1, Gau Shoua Vue1, Benedetta Assetta2, Heather Manza1, Walter J Atwood2, Michael J Imperiale3.   

Abstract

BK polyomavirus (BKPyV) is a ubiquitous human pathogen, with over 80% of adults worldwide being persistently infected. BKPyV infection is usually asymptomatic in healthy people; however, it causes polyomavirus-associated nephropathy in renal transplant patients and hemorrhagic cystitis in bone marrow transplant patients. BKPyV has a circular, double-stranded DNA genome that is divided genetically into three parts: an early region, a late region, and a noncoding control region (NCCR). The NCCR contains the viral DNA replication origin and cis-acting elements regulating viral early and late gene expression. It was previously shown that a BKPyV microRNA (miRNA) expressed from the late strand regulates viral large-T-antigen expression and limits the replication capacity of archetype BKPyV. A major unanswered question in the field is how expression of the viral miRNA is regulated. Typically, miRNA is expressed from introns in cellular genes, but there is no intron readily apparent in BKPyV from which the miRNA could derive. Here, we provide evidence for primary RNA transcripts that circle the genome more than once and include the NCCR. We identified splice junctions resulting from splicing of primary transcripts circling the genome more than once, and Sanger sequencing of reverse transcription-PCR (RT-PCR) products indicates that there are viral transcripts that circle the genome up to four times. Our data suggest that the miRNA is expressed from an intron spliced out of these greater-than-genome-size primary transcripts.IMPORTANCE The BK polyomavirus (BKPyV) miRNA plays an important role in regulating viral large-T-antigen expression and limiting the replication of archetype BKPyV, suggesting that the miRNA regulates BKPyV persistence. However, how miRNA expression is regulated is poorly understood. Here, we present evidence that the miRNA is expressed from an intron that is generated by RNA polymerase II transcribing the circular viral genome more than once. We identified splice junctions that could be generated only from primary transcripts that contain tandemly repeated copies of the viral genome. The results indicate another way in which viruses optimize expression of their genes using limited coding capacity.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  BKPyV; RNA splicing; miRNA; polyomavirus

Mesh:

Substances:

Year:  2020        PMID: 33115878      PMCID: PMC7944457          DOI: 10.1128/JVI.01589-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Human polyomavirus JC and BK persistent infection.

Authors:  Kristina Doerries
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  Characterization of the polyomavirus late polyadenylation signal.

Authors:  D B Batt; G G Carmichael
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

3.  Leader-to-leader splicing is required for efficient production and accumulation of polyomavirus late mRNAs.

Authors:  G R Adami; C W Marlor; N L Barrett; G G Carmichael
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression.

Authors:  Gil Ju Seo; Chun Jung Chen; Christopher S Sullivan
Journal:  Virology       Date:  2008-11-30       Impact factor: 3.616

5.  Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors.

Authors:  Adrian Egli; Laura Infanti; Alexis Dumoulin; Andreas Buser; Jacqueline Samaridis; Christine Stebler; Rainer Gosert; Hans H Hirsch
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

Review 6.  Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis.

Authors:  U Moens; T Johansen; J I Johnsen; O M Seternes; T Traavik
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

7.  miRNA regulation of BK polyomavirus replication during early infection.

Authors:  Nicole M Broekema; Michael J Imperiale
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

8.  Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs.

Authors:  Erika Varkonyi-Gasic; Rongmei Wu; Marion Wood; Eric F Walton; Roger P Hellens
Journal:  Plant Methods       Date:  2007-10-12       Impact factor: 4.993

9.  A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence.

Authors:  Juliane Marie Theiss; Thomas Günther; Malik Alawi; Friederike Neumann; Uwe Tessmer; Nicole Fischer; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2015-07-28       Impact factor: 6.823

10.  BK polyomavirus infection promotes growth and aggressiveness in bladder cancer.

Authors:  Yigang Zeng; Jiajia Sun; Juan Bao; Tongyu Zhu
Journal:  Virol J       Date:  2020-09-14       Impact factor: 4.099

View more
  3 in total

1.  BK Polyomavirus bkv-miR-B1-5p: A Stable Micro-RNA to Monitor Active Viral Replication after Kidney Transplantation.

Authors:  Baptiste Demey; Marine Bentz; Véronique Descamps; Virginie Morel; Catherine Francois; Sandrine Castelain; Francois Helle; Etienne Brochot
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 2.  Biology of Polyomavirus miRNA.

Authors:  Wei Zou; Michael J Imperiale
Journal:  Front Microbiol       Date:  2021-04-06       Impact factor: 5.640

3.  Long-read sequencing reveals complex patterns of wraparound transcription in polyomaviruses.

Authors:  Jason Nomburg; Wei Zou; Thomas C Frost; Chandreyee Datta; Shobha Vasudevan; Gabriel J Starrett; Michael J Imperiale; Matthew Meyerson; James A DeCaprio
Journal:  PLoS Pathog       Date:  2022-04-01       Impact factor: 7.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.